Relay Therapeutics, Inc.
RLAY
$7.77
$0.283.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -91.18% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -91.18% | |||
| Cost of Revenue | 10.44% | -16.71% | |||
| Gross Profit | -11.67% | 8.07% | |||
| SG&A Expenses | -9.09% | -26.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.87% | -18.72% | |||
| Operating Income | -7.84% | 12.16% | |||
| Income Before Tax | -5.36% | 8.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.36% | 8.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.36% | 8.68% | |||
| EBIT | -7.84% | 12.16% | |||
| EBITDA | -8.29% | 12.09% | |||
| EPS Basic | -4.67% | 9.77% | |||
| Normalized Basic EPS | -8.21% | 12.72% | |||
| EPS Diluted | -4.67% | 9.77% | |||
| Normalized Diluted EPS | -8.21% | 12.72% | |||
| Average Basic Shares Outstanding | 0.66% | 1.20% | |||
| Average Diluted Shares Outstanding | 0.66% | 1.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||